Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia

被引:5
|
作者
Hrabovsky, Stepan [1 ,2 ]
Folber, Frantisek [1 ,2 ]
Horacek, Jan M. [3 ,4 ,5 ]
Stehlikova, Olga [1 ,2 ]
Jelinkova, Hana [1 ,2 ]
Salek, Cyril [6 ,7 ]
Doubek, Michael [1 ,2 ,8 ]
机构
[1] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Brno, Czech Republic
[3] Univ Hosp Hradec Kralove, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic
[4] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
[5] Univ Def, Dept Mil Internal Med & Hyg, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic
[6] Inst Hematol & Blood Transfus, Prague, Czech Republic
[7] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[8] Cent European Inst Technol, Brno, Czech Republic
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷 / 11期
关键词
ALL; FCM; MRD; Overall survival; Sensitivity; STANDARD-RISK; MRD; PCR; RELAPSE;
D O I
10.1016/j.clml.2018.06.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the usefulness of flow cytometry (FCM) and real-time quantitative polymerase chain reaction (PCR) in the assessment of minimal residual disease (MRD) in adult acute lymphoblastic leukemia. The analysis showed that both FCM and real-time quantitative PCR MRD methods are sensitive for survival prediction during induction. However, FCM was not sufficiently sensitive in later phases of treatment. Background: Minimal residual disease (MRD) is an important prognostic maker in acute lymphoblastic leukemia (ALL). However, few data comparing the measurement of adult ALL MRD using different methods in daily practice are available. We conducted an analysis comparing the importance of flow cytometry (FCM) and real-time quantitative polymerase chain reaction (PCR) in the assessment of MRD in adult ALL. Patients and Methods: Fifty-six consecutive adult patients with both Philadelphia-negative and -positive ALL treated according to an intensive protocol were enrolled in the study. Bone marrow samples were acquired on day 26 and during week 11 of treatment. MRD evaluation was performed using 8-color FCM and PCR of immunoglobulin or T-cell receptor gene clonal rearrangements and BCR-ABL1, KMT2A-AF4 and E2A-PBX1 fusion genes. Results: On day 26, both FCM and PCR seemed to have good discrimination sensitivity for overall survival (P =.001 to.008) and progression-free survival (P =.03 to.04) prediction for both Philadelphia-positive and -negative cases. The most sensitive method in week 11 was PCR including all results > 0 considered to indicate MRD positivity (P =.002 for overall survival and P =.02 for progression-free survival). PCR with other cutoffs was not sufficiently sensitive in week 11. Moreover, no FCM thorn samples were found in week 11. The subanalysis of the Philadelphia-negative patients showed similar results. Conclusion: Our analysis showed that both FCM and PCR MRD assessment methods are sensitive for survival prediction during induction. However, we believe FCM could not be sufficiently sensitive in later phases of treatment. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 50 条
  • [31] Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes
    Yalniz, Fevzi F.
    Patel, Keyur P.
    Bashir, Qaiser
    Marin, David
    Ahmed, Sairah
    Alousi, Amin M.
    Chen, Julianne
    Ciurea, Stefan O.
    Rezvani, Katy
    Popat, Uday R.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Oran, Betul
    CANCER, 2020, 126 (10) : 2183 - 2192
  • [32] Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight-Color Tube with Dried Antibody ReagentsKey terms
    Bouriche, Lakhdar
    Bernot, Denis
    Nivaggioni, Vanessa
    Arnoux, Isabelle
    Loosveld, Marie
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (02) : 158 - 163
  • [33] Real-time PCR for quantitative detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL)
    Pongers-Willemse, MJ
    Verhagen, OJHM
    Tibbe, GJM
    Wijkhuijs, JM
    De Haas, V
    Van Wering, ER
    Van der Schoot, CE
    Van Dongen, JJM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 292 - 292
  • [34] Direct comparison of polymerase chain reaction-based and multiparameter flow cytometry-based assessment of minimal residual disease in patients with acute myeloid leukemia.
    Kern, W
    Danhauser-Riedl, S
    Schoch, C
    Haferlach, T
    Hiddemann, W
    Schnittger, S
    BLOOD, 2001, 98 (11) : 583A - 583A
  • [35] Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma
    Ladetto, M
    Donovan, JW
    Harig, S
    Weller, E
    Trojan, A
    Poor, C
    Schlossman, R
    Anderson, KC
    Gribben, JG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (03) : 241 - 253
  • [36] Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance
    Della Starza, Irene
    Cavalli, Marzia
    Del Giudice, Ilaria
    Barbero, Daniela
    Mantoan, Barbara
    Genuardi, Elisa
    Urbano, Marina
    Mannu, Claudia
    Gazzola, Anna
    Ciabatti, Elena
    Guarini, Anna
    Foa, Robin
    Galimberti, Sara
    Piccaluga, Pierpaolo
    Gaidano, Gianluca
    Ladetto, Marco
    Monitillo, Luigia
    HEMATOLOGICAL ONCOLOGY, 2014, 32 (03) : 133 - 138
  • [37] Improved Concordance of Minimal Residual Disease Measurements By Quantitative PCR and 10-Color Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia
    Sartor, Mary
    Barbaric, Draga
    Law, Tamara
    Dissanayake, Anuruddhika
    Venn, Nicola C.
    Karsa, Mawar
    Wong, Sue W. J.
    Norris, Murray D.
    Revesz, Tamas
    Ritchie, Petra
    Shaw, Peter J.
    Bradstock, Kenneth F.
    Pozza, Luciano Dalla
    Trahair, Toby N.
    Sutton, Rosemary
    BLOOD, 2015, 126 (23)
  • [38] Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR
    Kerst, G
    Kreyenberg, H
    Roth, C
    Well, C
    Dietz, K
    Coustan-Smith, E
    Campana, D
    Koscielniak, E
    Niemeyer, C
    Schlegel, PG
    Müller, I
    Niethammer, D
    Bader, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) : 774 - 782
  • [39] Quantitative determination of minimal residual disease by low cytometry in patients with acute lymphoblastic leukemia
    Rendon-Garcia, Homero
    Alvarez-Hernandez, Gerardo
    Covarrubias-Espinoza, Gilberto
    Ramos-Salazar, Alfonso
    Guadalupe Burboa-Zazueta, Maria
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (03): : 152 - 156
  • [40] Comparison of polymerase chain reaction (PCR) and flow cytometry (FC) for the detection of minimal residual disease (MRD) in pediatric acute lymphoblastic leukemia (ALL): A pediatric oncology group study.
    Viswanatha, DS
    Bartolo, C
    Chen, IM
    Camitta, B
    Pullen, J
    Willman, CL
    Borowitz, M
    BLOOD, 2000, 96 (11) : 314A - 314A